Bardelli A, Maina F, Gout I, Fry MJ, Waterfield MD, Comoglio PM, Ponzetto C

Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains.

Oncogene 1992; 1973-8.

Leggi ora
Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK

Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

EMBO J 1991; 2867-78. doi: 10.1002/j.1460-2075.1991.tb07836.x

Leggi ora
Bardelli AM, Rottoli P, Panzardi G, Traversi C, Barberi L, Vagliasindi M

Unusual optic nerve lesion in sarcoidosis.

Sarcoidosis 1991; 72-4.

Leggi ora
Bardelli AM, Hadjistilianou T

Buphthalmos and progressive elephantiasis in neurofibromatosis. A report of three cases.

Ophthalmic Paediatr Genet 1989; 279-86. doi: 10.3109/13816818909009883

Leggi ora
Dotti MT, Rossi A, Rizzuto N, Hayek G, Bardelli N, Bardelli AM, Federico A

Atypical phenotype of Refsum's disease: clinical, biochemical, neurophysiological and pathological study.

Eur Neurol 1985; 85-93. doi: 10.1159/000115767

Leggi ora
Mastrangelo D, Di Pisa F, Hadjistilianou T, Bardelli AM, Silvestri S, Frezzotti R

Retinoblastoma. Analysis of 75 cases and proposal for a new model of oncogenesis and tumor growth kinetics.

Ophthalmic Paediatr Genet 1989; 161-71. doi: 10.3109/13816818909009872

Leggi ora
Bardelli A, Rebora A

Telogen effluvium and minoxidil.

J Am Acad Dermatol 1989; 572-3. doi: 10.1016/s0190-9622(89)80231-2

Leggi ora
Bardelli AM, Lasorella G, Vanni M

Congenital and developmental cataracts and multimalformation syndromes.

Ophthalmic Paediatr Genet 1989; 293-8. doi: 10.3109/13816818909009885

Leggi ora
Federico A, Manneschi L, Meloni M, Alessandrini C, Bardelli AM, Dotti MT, Sabatelli P

Histochemical, ultrastructural and biochemical study of muscle mitochondria in Leber's hereditary optic atrophy.

J Inherit Metab Dis 1988; 193-7. doi: 10.1007/BF01804233

Leggi ora
Pallini R, Martelli P, Bardelli AM, Guazzi GC, Federico A

Normal rhodanese activity in leukocytes from Leber patients: enzyme characterization and activity levels.

Neurology 1987; 1878-80. doi: 10.1212/wnl.37.12.1878

Leggi ora
Annunziata P, Pero G, Ibba L, Federico A, Bardelli AM, Sabatelli P, Guazzi GC

Adult dementia in three siblings: ceroid-lipofuscinosis.

Acta Neurol (Napoli) 1986; 528-34.

Leggi ora
Rebora A, Bardelli A, Parodi A

Discoid lupus erythematosus of the palms.

J Dermatol 1985; 195-7. doi: 10.1111/j.1346-8138.1985.tb01559.x

Leggi ora
Bardelli AM, Hadjistilianou T, Barberi L

Aicardi's syndrome.

Ophthalmic Paediatr Genet 1985; 141-4. doi: 10.3109/13816818509006125

Leggi ora
Bardelli AM, Lasorella G, Barberi L, Vanni M

Ocular manifestations in Kniest syndrome, Smith-Lemli-Opitz syndrome, Hallermann-Streiff-François syndrome, Rubinstein-Taybi syndrome and median cleft face syndrome.

Ophthalmic Paediatr Genet 1985; 343-7.

Leggi ora
Fois A, Bardelli AM, Frezzotti R, Acquaviva A, Bernardini C, Hadjistilianou T

Combined treatment modalities of orbital rhabdomyosarcoma in children.

Eur J Pediatr 1986; 514-5. doi: 10.1007/BF00441754

Leggi ora
Bardelli AM, Biagini L, Barberi L

Leber's optic neuritis.

Ophthalmic Paediatr Genet 1985; 133-40. doi: 10.3109/13816818509006124

Leggi ora
Bardelli AM, Hadjistilianou T, Frezzotti R

Etiology of congenital glaucoma. Genetic and extragenetic factors.

Ophthalmic Paediatr Genet 1985; 265-70.

Leggi ora
Frezzotti R, Bardelli AM, Morocutti A, Pannini S

The pars plana approach in two cases of persistent hyperplastic primary vitreous (PHPV).

Ophthalmic Paediatr Genet 1984; 107-10. doi: 10.3109/13816818409007845

Leggi ora
Bardelli A, Parodi A, Rebora A

[Discoid lupus erythematosus as a sign of systemic lupus erythematosus].

G Ital Dermatol Venereol 1983; 195-8.

Leggi ora
Bardelli AM, Lasorella G

Primary and secondary ocular tumors in children.

J Neurosurg Sci 1982; 11-6.

Leggi ora
Giuffrè R, Bardelli AM, Taverniti L, Barberi L

Anterior optic pathways gliomas. The dilemma of treatment.

J Neurosurg Sci 1982; 61-72.

Leggi ora
Motolese E, Esposti P, Bardelli AM, Frezzotti R

Echographic study of exophthalmos and neoformative endocular pathology in childhood.

J Neurosurg Sci 1982; 17-20.

Leggi ora
Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G, Comoglio PM

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

Cell 1994; 261-71. doi: 10.1016/0092-8674(94)90318-2

Leggi ora
Ponzetto C, Bardelli A, Maina F, Longati P, Panayotou G, Dhand R, Waterfield MD, Comoglio PM

A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor.

Mol Cell Biol 1993; 4600-8. doi: 10.1128/mcb.13.8.4600-4608.1993

Leggi ora
Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfield MD, Ponzetto C, Pelicci PG

The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein.

Oncogene 1995; 1631-8.

Leggi ora
Bardelli A, Ponzetto C, Comoglio PM

Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.

J Biotechnol 1994; 109-22. doi: 10.1016/0168-1656(94)90002-7

Leggi ora
Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, Comoglio PM

Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction.

J Biol Chem 1995; 603-11. doi: 10.1074/jbc.270.2.603

Leggi ora
Vigna E, Naldini L, Tamagnone L, Longati P, Bardelli A, Maina F, Ponzetto C, Comoglio PM

Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.

Cell Mol Biol (Noisy-le-grand) 1994; 597-604.

Leggi ora
Bardelli AM, Barberi L, Vanni M, Mazzera L, Traversi C

Eye involvement in sarcoidosis: survey of 197 patients.

Sarcoidosis 1993; 158-9.

Leggi ora
Longati P, Bardelli A, Ponzetto C, Naldini L, Comoglio PM

Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor).

Oncogene 1994; 49-57.

Leggi ora
Dotti MT, Bardelli AM, De Stefano N, Federico A, Malandrini A, Vanni M, Guazzi GC

Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families.

Ophthalmic Paediatr Genet 1993; 5-7. doi: 10.3109/13816819309087616

Leggi ora
Bardelli AM

[Malformation syndromes: the diagnostic approach and follow-up in ocular pathology].

Pediatr Med Chir 1993; 34-7; discussion 37-8.

Leggi ora
Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA

The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.

Mol Cell Biol 1996; 2151-63. doi: 10.1128/MCB.16.5.2151

Leggi ora
Ponzetto C, Zhen Z, Audero E, Maina F, Bardelli A, Basile ML, Giordano S, Narsimhan R, Comoglio P

Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility.

J Biol Chem 1996; 14119-23. doi: 10.1074/jbc.271.24.14119

Leggi ora
Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C, Comoglio PM

HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death.

EMBO J 1996; 6205-12.

Leggi ora
Besser D, Bardelli A, Didichenko S, Thelen M, Comoglio PM, Ponzetto C, Nagamine Y

Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.

Oncogene 1997; 705-11. doi: 10.1038/sj.onc.1200879

Leggi ora
Giordano S, Bardelli A, Zhen Z, Menard S, Ponzetto C, Comoglio PM

A point mutation in the MET oncogene abrogates metastasis without affecting transformation.

Proc Natl Acad Sci U S A 1997; 13868-72. doi: 10.1073/pnas.94.25.13868

Leggi ora
Bardelli A, Pugliese L, Comoglio PM

"Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection.

Biochim Biophys Acta 1997; M41-51. doi: 10.1016/s0304-419x(97)00026-7

Leggi ora
Boccaccio C, Andò M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway.

Nature 1998; 285-8. doi: 10.1038/34657

Leggi ora
Bardelli A, Longati P, Gramaglia D, Stella MC, Comoglio PM

Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential.

Oncogene 1997; 3103-11. doi: 10.1038/sj.onc.1201561

Leggi ora
Battisti C, Dotti MT, Malandrini A, Pezzella F, Bardelli AM, Federico A

Schnyder corneal crystalline dystrophy: description of a new family with evidence of abnormal lipid storage in skin fibroblasts.

Am J Med Genet 1998; 35-9. doi: 10.1002/(sici)1096-8628(19980106)75:1<35::aid-ajmg8>3.0.co;2-p

Leggi ora
Bardelli A, Comoglio PM

Scatter factor receptors are key players in a unique multistep program leading to invasive growth.

Ciba Found Symp 1997; 133-44; discussion 144-7. doi: 10.1002/9780470515457.ch9

Leggi ora
Villa-Moruzzi E, Puntoni F, Bardelli A, Vigna E, De Rosa S, Comoglio PM

Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met.

Biochem J 1998; 235-9. doi: 10.1042/bj3360235

Leggi ora
Bardelli A, Longati P, Gramaglia D, Basilico C, Tamagnone L, Giordano S, Ballinari D, Michieli P, Comoglio PM

Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth.

Proc Natl Acad Sci U S A 1998; 14379-83. doi: 10.1073/pnas.95.24.14379

Leggi ora
Bardelli A, Basile ML, Audero E, Giordano S, Wennström S, Ménard S, Comoglio PM, Ponzetto C

Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.

Oncogene 1999; 1139-46. doi: 10.1038/sj.onc.1202607

Leggi ora
Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, Terrone C, Rocca-Rossetti S, Comoglio PM, Di Renzo MF

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.

Int J Cancer 1999; 640-3. doi: 10.1002/(sici)1097-0215(19990827)82:5<640::aid-ijc4>3.0.co;2-6

Leggi ora
Vigna E, Gramaglia D, Longati P, Bardelli A, Comoglio PM

Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.

Oncogene 1999; 4275-81. doi: 10.1038/sj.onc.1202791

Leggi ora
Michieli P, Basilico C, Pennacchietti S, Maffè A, Tamagnone L, Giordano S, Bardelli A, Comoglio PM

Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.

Oncogene 1999; 5221-31. doi: 10.1038/sj.onc.1202899

Leggi ora
Bardelli A, Longati P, Williams TA, Benvenuti S, Comoglio PM

A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth.

J Biol Chem 1999; 29274-81. doi: 10.1074/jbc.274.41.29274

Leggi ora
Williams TA, Longati P, Pugliese L, Gual P, Bardelli A, Michieli P

MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.

J Cell Physiol 1999; 507-14. doi: 10.1002/(SICI)1097-4652(199912)181:3<507::AID-JCP15>3.0.CO;2-Q

Leggi ora
%PLACEHOLDER%